Abstract Four chromone derivatives (1-4) were isolated from the clove buds (Syzygium aromaticum). Of these, two chromone C-glucosides (1 and 2) showed significant PEP inhibition with IC 50 values of 1.48±0.02 and 1.74±0.03 µM and K i values of 0.27±0.02 and 0.50±0.05 µM, respectively. They also exhibited strong antioxidant capacities against the 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid diammonium salt radical system with EC 50 values of 4.13±0.04 and 4.79±0.03 µM, respectively.
successfully partitioned to afford hexane-, EtOAc-, and BuOHsoluble fractions. The BuOH-soluble fraction (25 g) was subjected to ODS column (190 mm × 30 mm) eluting with CH 3 CN/H 2 O (1:9→5:5) to afford five fractions. The fourth fraction (1.5 g) was subjected to reversed phase HPLC [10-50% CH 3 CN/0.1% trifluoroacetic acid (TFA)-H 2 O, ODS column; 250 mm × 10 mm, MD2010 UV PDA detector (JASCO, Japan)] to yield two chromone C-glucosides, 8-C-β-D-(6-O-galloyl)glucosylnoreugenin (1, 30 mg, R t 36.7 min) and 6-C-β-D-(6'-O-galloyl)glucosylnoreugenin (2, 27 mg, R t 41.1 min). Two chromones, 5-methoxyeugenin (3, 30 mg, R t 54.5 min) and 5-methoxyisoeugenitin (4, 26 mg, R t 68.0 min), were obtained from the fifth fraction (1.7 g) by reversed phase HPLC (10-50% CH 3 CN/0.1% TFA-H 2 O, then 100% MeOH). (Table 1) were in accordance with published data (Tanaka et al., 1993 
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C-NMR data were in accordance with published data (Kalinin and Snieckus, 1998) . C-, and HMBC spectra of 1 (Table  1) were in good agreement with those of reported 8-C-β-D-(6-Ogalloyl)glucosylnoreugenin from the leaves of S. aromaticum (Tanaka et al., 1993) . The positive HRFABMS of compound 2 showed a [M+H] + ion at 507.1136, indicating the molecular formula of 2 (C 23 H 22 O 13 ) is the same as that of 1. The UV spectrum pattern of compound 2 (λ max at 275, 258 and 209 nm) was also very similar with that of 1 (λ max at 280, 259, and 219 nm) suggesting their isomeric relationship. The chemical shifts of 
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C-NMR spectra of 2 were in good agreement with those of 1, except for the different chemical shifts at C-6 and C-8 (Table 1 ). In the HMBC spectrum of 2, there is a correlation with C-8 proton signal at δ 6.34 and C-6, 7, 8, 9 and 10 carbon signals. Also, there is a correlation with glucose C-1 proton signals at δ 4.91 and C-5, 6 and 7 carbon signals, indicating the location of the C-glycosyl moiety to be at the C-6 position. These observations suggested that 2 is 6-C-β-D-(6'-O-galloyl)glucosylnoreugenin.
The positive HRFABMS of compound 3 showed a [M+H] + ion at 221.0815, suggesting the molecular formula of 3 as C 12 H 12 O 4 . The 1 H-and 13 C-NMR spectra of 3 were closely related with those of eugenin (Coxon et al., 1973; Han and Paik, 2010) , except for the appearance of a methoxy group (δ H 3.85 and δ C 56.63). The position of this methoxy group was verified by HMBC spectrum; the methoxy proton signal at δ 3.85 is connected to δ 162.13 (C-5). These observations suggested that 3 is 5-methoxyeugenin. The 1 H-and 13 C-NMR spectra of 4 were in accordance with published data of 5-methoxyisoeugenitin (Kalinin and Snieckus, 1998) . There is a possibility that compound 3 and 4 are O-methylated artifacts formed during extraction and isolation.
The PEP inhibitory activity of each compound was assayed using benzyloxycarbonyl-glycyl-L-prolyl-p-nitroanilide (Z-GlyPro-pNA) as a substrate, and the amount of released p-nitroaniline was determined at 380 nm (Lee et al., 2004) . Upon preliminary examination of 1-4 at 8 µg/mL, compounds 1-3 inhibited PEP activity almost completely (larger than 95%), whereas compound 4 showed much less PEP inhibitory activity as shown in Fig. 2 . Fig. 2 Typical inhibition pattern of p-nitroaniline produced from the reaction of Z-Gly-pro-pNA with PEP at 380 nm in the absence and presence of compounds 1-4 (8 µg/mL). Compounds 1-3 showed dose-dependent PEP inhibitory effects with IC 50 values of 1.48±0.02, 1.74±0.03, and 10.96±0.02 µM, respectively ( Table 2 ). The IC 50 values of these compounds, especially 1 and 2, were strong enough and comparable to those reported for other natural inhibitors such as ginkgolic acid (0.62 µM), ursolic acid (17.2 µM), oleanolic acid (22.5 µM), and oleic acid (23.6 µM) (Lee et al., 2004; Park et al., 2005; 2006) , suggesting that they may have potential use as bioactive drug against cognitive decline and prevention of memory loss. Lineweaver-Burk and Dixon plots of the PEP inhibition by compounds 1 (Fig. 3) indicate that 1 is competitive inhibitor with K i value of 0.27±0.02 µM (Table 2 ). Compound 2 also shows competitive inhibition with K i value of 0.50±0.05 µM ( Table 2) . The exact mechanism involved in the PEP inhibition by these compounds remains to be elucidated.
Measurement of the radical-scavenging activities of compounds 1-4 was carried out using the decolorization of ABTS radical at 734 nm (Yoon and Paik, 2010) . Compounds 1-3 and Trolox (standard reference compound; EC 50 14.4±0.22 µM) showed dose-dependent effects on the ABTS radical (Fig. 4) , whereas compound 4 did not show any radical-scavenging effect. EC 50 values of 1-3 (Table 2) were 4.13±0.04, 4.79±0.03, and 32.7±0.5 µM, respectively, indicating 1 and 2 have strong free radicalscavenging activities.
In summary, four chromone derivatives (1-4) were isolated from the BuOH soluble fraction of clove buds. Of these substances, 1 and 2 showed strong prolyl endopeptidase inhibitory effect with IC 50 values of 1.48 and 1.74 µM and K i values of 0.27 and 0.50 µM, respectively, suggesting they may have potential to use against cognitive decline. Compounds 1 and 2 also exhibited strong antioxidant capacities against the ABTS radical system with EC 50 values of 4.13 and 4.79 µM, respectively. 
